Stem Cell Agency Board Still in Closed Session
Directors of the $3 billion California stem cell agency are still meeting in closed session following a statement by its Chairman Robert Klein defending his actions in connection with an attempt to hand pick his successor.
The board went to lunch and into an executive session about two hours ago shortly after Klein orally laid out his view of what transp…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.